Health care's grand challenge: Stimulating basic science on diseases that primarily afflict the poor

Academy of Management Journal

Volumn 59, Issue 6, 2016, Pages 1917-1939

  Vakili, Keyvan ^a   McGahan, Anita M ^b  

^a LONDON BUSINESS SCHOOL   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007313586     PISSN: 00014273     EISSN: None     Source Type: Journal    
DOI: 10.5465/amj.2015.0641     Document Type: Conference Paper

References (38)

1. Agrawal, A., & Goldfarb, A. 2008. Restructuring research: Communication costs and the democratization of university innovation. The American Economic Review, 98: 1578-1590.
2. Balachandran, S., & Hernandez, E. 2016. Liberty in law: Intellectual property rights and global alliance networks. Working Paper.
3. Bertrand, M., Duflo, E., & Mullainathan, S. 2004. How much should we trust differences-in-differences estimates? The Quarterly Journal of Economics, 119: 249-275.
4. Bertrand, M., & Mullainathan, S. 2003. Enjoying the quiet life? Corporate governance and managerial preferences. Journal of Political Economy, 111: 1043-1075.
5. Bessen, S. M., & Raskind, L. J. 1991. An introduction to the law and economics of intellectual property. The Journal of Economic Perspectives, 5: 3-27.
6. Chatterjee, C., Inoue, C., & McGahan, A. M.(2016). Infrastructure and diffusion of medicines in developing countries: Evidence from HIV drugs in India 2007-2013. Working Paper. University of Toronto.
7. Cohen, W. M. 2010. Fifty years of empirical studies of innovative activity and performance. In B. H. Hall & N. Rosenburg, Handbook of the Economics of Innovation, vol. 1: 129-213. Amsterdam: Elsevier.
8. Daar, A., & Singer, P. 2013. The grandest challenge: Taking life-saving science from lab to village. Toronto: Anchor Canada.
9. Dasgupta, P., & David, P. A. 1994. Toward aneweconomics of science. Research Policy, 23: 487-521.
10. Delgado, M., Kyle, M., & McGahan, A. M. 2013. Intellectual property protection and the geography of trade. The Journal of Industrial Economics, 61: 733-762.
11. Eicher, T., & Rohn, O. 2007. Institutional determinants of economic performance in OECD countries: An institutions climate index. CESifoDiCEReport, 5: 38-49.
12. Furman, J. L., & Stern, S. 2011. Climbing atop the shoulders of giants: The impact of institutions on cumulative research. The American Economic Review, 101: 1933-1963.
13. Gans, J. S., & Stern, S. 2003. The product market and the market for "ideas": Commercialization strategies for technology entrepreneurs. Research Policy, 32: 333-350.
14. Gates Foundation 2014. Bill & Melinda Gates Foundation and Grand Challenge partners commit to innovation with new investments in breakthrough science. October 7. Available at http://www. gatesfoundation. org/Media-Center/Press-Releases/2014/10/Gates-Foundation-Grand-Challenges-Breakthrough-Science accessed June 29, 2015.
15. Ginarte, J. C., & Park, W. G. 1997. Determinants of patent rights: A cross-national study. Research Policy, 26: 283-301.
16. Hall, B. H., Jaffe, A., & Trajtenberg, M. 2005. Market value and patent citations. The Rand Journal of Economics, 36: 16-38.
17. Hamdan-Livramento, I. M. 2009. How compliant are developing countries with their TRIPS obligations. Chaire en Economie et Management de l'Innovation(CEMI), CEMI-WORKINGPAPER-2009-001, Ecole Polytechnique Federale de Lausanne, Switzerland.
18. Hellerstein, R. 2012. What do drug monopolies cost consumers in developing countries? Economics Letters, 116: 108-111.
19. Jaffe, A. B. 2000. The US patent system in transition: Policy innovation and the innovation process. Research Policy, 29(4): 531-557.
20. Jandhyala, S. 2014. International and domestic dynamics of international property. Journal of World Business, 50: 284-293.
21. Kaplan, S., & Vakili, K. 2015. The double?edged sword of recombination in breakthrough innovation. Strategic Management Journal, 36: 1435-1457.
22. Kerr, W. R. 2008. Ethnic scientific communities and international technology diffusion. The Review of Economics and Statistics, 90: 518-537.
23. Khwaja, A. I., & Mian, A. 2008. Tracing the impact of bank liquidity shocks: Evidence from an emerging market. The American Economic Review, 98: 1413-1442.
24. Kitch, E. W. 1977. The nature and function of the patent system. The Journal of Law & Economics, 20: 265-290.
25. Kuncic, A. 2014. Institutional quality dataset. Journal of Institutional Economics, 10: 135-161.
26. Kyle, M. K., & McGahan, A. M. 2012. Investments in pharmaceuticals before and after TRIPS. The Review of Economics and Statistics, 94: 1157-1172.
27. Lanjouw, J. O., & Cockburn, I. M. 2001. New pills for poor people? Empirical evidence after GATT. World Development, 29: 265-289.
28. Nelson, R. R. 1959. The economics of invention: A survey of the literature. The Journal of Business, 32: 101-127.
29. Rezaie, R., McGahan, A. M., Daar, A., & Singer, P. 2012. Globalization of health innovation. Nature Biotechnology, 30: 923-925.
30. Ryan, M. P. 2010. Patent incentives, technology markets, and public-private bio-medical innovation networks in Brazil. World Development, 38: 1082-1093.
31. Schwab, K., Sala-i-Martin, X., & Greenhill, R. 2011. The global competitiveness report 2011-2012. Geneva: World Economic Forum.
32. Seamans, R., & Zhu, F. 2013. Responses to entry in multi-sided markets: The impact of Craigslist on local newspapers. Management Science, 60: 476-493.
33. Singh, J., & Fleming, L. 2010. Lone inventors as sources of breakthroughs: Myth or reality? Management Science, 56: 41-56.
34. Teorell, J., Charron, N., Samanni, M., Holmberg, S., & Rothstein, B. 2011. The quality of government dataset. Working Paper. Available at: http://www. qog. pol. gu. se.
35. Weisberg, R. W. 1999. Creativity and knowledge: A challenge to theories. In R. J. Sternberg(Ed.), Handbook of creativity: 226-259. Cambridge, U. K. : Cambridge University Press.
36. Williams, H. L. 2013. Intellectual property rights and innovation: Evidence from the human genome. Journal of Political Economy, 121: 1-27.
37. Wilson, P., & Rao, A. 2012. India's role in global health R & D. Washington, DC: Results for Development Institute.
38. Yang, G. J., et al. 2014. China's sustained drive to eliminate neglected tropical diseases. The Lancet Infectious Diseases, 14: 881-892.